Estée Lauder Returns to Growth as Transformation Strategy Takes Hold
The prestige beauty company delivered 3% organic sales growth and 66% EPS growth in fiscal 2026, exceeding initial guidance as its profit recovery plan accelerates.
Transformation Delivers Results
The Estée Lauder Companies returned to growth in fiscal 2026, with organic sales rising 3% and operating margin expanding 320 basis points, significantly exceeding initial guidance as the company's profit recovery and growth plan (PRGP) delivered results faster than anticipated (earnings call, 2026-08-19).
Reported sales increased 5%, while diluted earnings per share surged 66%. The company generated $1.8 billion in net cash flows from operations during the year.
"We reignited growth with organic sales rising 3%, driven by the breadth of growth across brands and expanded operating margin significantly," said CEO Stephane de la Faverie, who is 18 months into his tenure (earnings call, 2026-08-19).
Portfolio Expansion and Regional Performance
Jo Malone London and TOM FORD joined Estée Lauder's billion-dollar brand club, bringing the total to six alongside Clinique, Estée Lauder, La Mer, and M.A.C. The Ordinary is "quickly ascending towards this milestone, fueled by another year of double-digit organic sales growth" (earnings call, 2026-08-19).
Mainland China led regional performance with 9% organic sales growth, outperforming the market every quarter to gain prestige beauty share. The company's priority emerging markets accelerated from mid-single digit growth in fiscal 2025 to high single digits in fiscal 2026.
The U.S. returned to organic sales growth in the fourth quarter, with retail sales rising mid-single digits and the company gaining prestige beauty volume share across every category for the full year. Online sales reached a record 34% of reported sales, up three percentage points from the prior year.
Category Performance
Skin care delivered 4% organic sales growth, with strength across price tiers. Fragrance led with 10% organic sales growth, among "the best in the industry," driven by Le Labo, TOM FORD, KILIAN PARIS, and Jo Malone London (earnings call, 2026-08-19). The company also launched Balmain Beauty into the prestige price tier.
Makeup performance stabilized, with organic sales trends improving 500 basis points, led by M.A.C and TOM FORD.
Strategic Focus and M&A Stance
Addressing market speculation, de la Faverie clarified the company's approach to acquisitions: "We will continue to pursue minority and single brand deals that enhance our portfolio and can benefit from our ability to create scale and deliver attractive ROIC," citing successes with KILIAN PARIS, La Labo, and The Ordinary (earnings call, 2026-08-19).
He emphasized: "To be clear, for the foreseeable future, we are not entertaining transformational deals that will divert us from our winning strategy" (earnings call, 2026-08-19).
Fiscal 2027 Outlook
Looking ahead, the company plans to increase innovation as a percentage of sales by 200 to 250 basis points in fiscal 2027, led by skin care. The first quarter kicked off with extensive launches across categories, including M.A.C's new Lipstain, which was "a blockbuster success in its early launch in Korea during fiscal '26" (earnings call, 2026-08-19).
The company continues deploying its One ELC operating model, recently launching macusbrand.com on Shopify with plans for many more deployments across brands and markets during fiscal 2027.
This article was generated by MarginX from the earnings call on 2026-08-19. It is not investment advice.